Intestinal Damage: Causes, Symptoms, and Treatment

Intestinal damage refers to any injury to the lining or deeper layers of the small or large bowel, and it spans a surprisingly wide range of causes, from common painkillers and bacterial infections to autoimmune disease and radiation therapy. The gut lining is only a single cell layer thick in most places, which makes it both remarkably efficient at absorbing nutrients and remarkably vulnerable to harm. When that lining breaks down, the consequences go well beyond digestive discomfort: bacteria and their toxic byproducts can leak into the bloodstream, triggering inflammation that reaches the liver, blood vessels, and metabolic organs far from the gut itself.

What the Intestinal Barrier Actually Does

Your intestinal lining does two jobs at once. It absorbs water, nutrients, and electrolytes from digested food, and it keeps everything else out, including trillions of bacteria, undigested food particles, and bacterial toxins. The cells that form this barrier are stitched together by protein complexes called tight junctions, which act like seals between neighboring cells. When those seals are intact, only small, selected molecules pass through. When they loosen or break apart, larger molecules and bacteria slip between cells and reach tissues they should never contact.

Beyond the physical seal, the gut also deploys chemical defenses. Specialized cells produce antimicrobial proteins that keep bacteria in check, while an enzyme called intestinal alkaline phosphatase detoxifies a particularly dangerous bacterial molecule, lipopolysaccharide (LPS), before it can trigger inflammation locally or leak into the circulation.¹ When intestinal damage knocks out any part of this system, the result is a chain reaction that begins with local inflammation and can escalate to system-wide problems.

Medications That Harm the Gut Lining

Nonsteroidal anti-inflammatory drugs, the broad category that includes ibuprofen, naproxen, and aspirin, are among the most common causes of intestinal injury. Most people associate NSAIDs with stomach ulcers, but these drugs also damage the small intestine through a separate mechanism. NSAIDs block prostaglandin production, which removes a protective factor in the stomach, but in the small bowel the damage appears to involve something different: the drugs uncouple a key energy-producing process inside cells, draining them of the fuel they need to maintain their defenses against harsh luminal contents.² In animal studies, stomach erosions appeared within hours, while small intestinal ulcers took a day or two to develop, suggesting two distinct injury pathways from the same pill.

The practical takeaway is that long-term NSAID use can silently erode the small intestine even when you have no stomach symptoms. If you rely on these drugs regularly for pain management, the risk of intestinal bleeding, strictures, or protein loss is real, and it’s worth discussing alternatives or protective strategies with a doctor.

Infections That Reach the Stem Cells

Bacterial and viral infections can devastate the gut lining, but some pathogens do more lasting damage than others. Clostridioides difficile, the bacterium responsible for severe antibiotic-associated diarrhea, produces toxins (TcdA and TcdB) that don’t just strip away the surface cells. Research in mice has shown that C. difficile infection disrupts the cellular organization deep enough to expose the otherwise protected stem cell compartment at the base of intestinal crypts.³ These stem cells are the gut’s repair crew; they constantly divide to replace the surface lining, which turns over every few days. When the stem cells themselves are damaged, the gut’s ability to heal is impaired, which helps explain why severe C. difficile infections can become chronic and relapsing.⁴

Other gut infections, from Salmonella to parasitic organisms, damage the lining through different routes but share a common thread: the faster the surface cells are destroyed, the more the barrier fails, and the more bacteria and toxins translocate into deeper tissues, amplifying inflammation.

Autoimmune and Immune-Mediated Injury

In inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, the immune system attacks the intestinal lining. The damage is driven by inflammatory signaling molecules called cytokines, particularly TNF and interferon-gamma. These cytokines degrade tight junction proteins: they downregulate occludin, a protein that helps seal the gaps between cells, while upregulating claudin-2, a protein that forms pores and increases the passage of water and ions between cells. The net effect is a leakier barrier that promotes the watery diarrhea characteristic of active IBD.⁵

Celiac disease is another major immune-mediated cause. When someone with celiac disease eats gluten, the immune response flattens the finger-like villi that line the small intestine, drastically reducing the surface area available for nutrient absorption. Celiac disease is the leading cause of this kind of villous atrophy, though it isn’t the only one. Occasionally, other conditions, or even certain blood pressure medications like olmesartan, can trigger a similar pattern of damage without the typical celiac antibodies showing up in blood tests, making diagnosis tricky.⁶

Radiation, Ischemia, and Other Physical Insults

Radiation therapy for abdominal or pelvic cancers can cause significant intestinal injury, both acutely and months to years later. Radiation damages the DNA of rapidly dividing crypt cells, triggering a cascade of cell death. In animal studies, exposure to radiation caused a wave of cytochrome c release (a signal that initiates programmed cell death) within hours, followed by the disintegration of the supportive cells surrounding the crypts within about a day, which coincided with a measurable increase in crypt leakiness.⁷ Radiation also disrupts the gut microbiome and damages the blood vessel lining within the intestinal wall, compounding the injury.⁸

Ischemia, a temporary loss of blood flow to the intestine, causes a different pattern of damage but an equally devastating one. When blood flow drops and then returns (ischemia-reperfusion), the restored oxygen generates a burst of reactive molecules that attack the lining. Animal experiments have shown sharp increases in markers of mucosal bleeding and protein leakage after ischemia-reperfusion, along with a spike in inflammatory cell activity and tissue-damaging oxidation products.⁹ Intestinal ischemia is a medical emergency, most often seen in older adults with vascular disease or after major abdominal surgery.

Stress and the Gut-Brain Connection

Psychological stress is an underappreciated contributor to intestinal barrier dysfunction. When you’re stressed, your body releases corticotropin-releasing hormone (CRH), which directly affects the gut. In one human experiment, a single intravenous dose of CRH increased intestinal permeability as measured by the passage of sugar molecules through the gut wall.¹⁰ The mechanism involves mast cells in the intestinal lining, which carry CRH receptors. Under stress, these mast cells degranulate, releasing inflammatory mediators that loosen tight junctions and increase permeability.¹¹

This doesn’t mean stress alone will give you a bowel disease. But chronic psychological stress can weaken a barrier that is already compromised by other factors, like medication use or a genetic predisposition to IBD, tipping a marginal situation into a symptomatic one.

Symptoms to Watch For

Intestinal damage doesn’t always announce itself with dramatic symptoms, especially early on. The signs depend on where the damage is, how deep it goes, and what caused it. Some common patterns include:

• Chronic diarrhea: Often watery if the damage affects the colon and tight junctions are leaking fluid, or fatty and foul-smelling if villous atrophy in the small bowel is blocking fat absorption.
• Abdominal pain and cramping: Can be diffuse or localized, and in ischemia, the pain is often severe and disproportionate to what a physical exam shows.
• Bloating and gas: Common when the damaged lining can’t properly absorb carbohydrates, which then ferment in the colon.
• Unintentional weight loss: A hallmark of significant small bowel damage, where nutrient absorption is compromised.
• Blood in the stool: Frank red blood suggests colonic damage, while dark, tarry stools point to injury higher up in the small intestine or stomach.
• Fatigue and nutrient deficiencies: Iron, vitamin B12, folate, and fat-soluble vitamins (A, D, E, K) are commonly depleted when the absorptive surface is damaged.

One of the frustrating things about mild intestinal damage is that symptoms overlap heavily with irritable bowel syndrome, food intolerances, and dozens of other conditions. The presence of blood, sustained weight loss, or signs of nutrient deficiency should prompt a closer look.

How Intestinal Damage Is Diagnosed

Endoscopy remains the gold standard for directly visualizing the intestinal lining. In IBD, clinicians use standardized scoring systems to rate the severity of what they see through the scope. For ulcerative colitis, the Mayo endoscopic score is the most widely used, while Crohn’s disease is assessed with scores like the SES-CD. A newer index, the Ulcerative Colitis Endoscopic Index of Severity (UCEIS), provides a more detailed breakdown of individual features like vascular pattern, bleeding, and erosions.¹² These scores aren’t just academic; they guide treatment decisions and help track whether therapies are actually healing the lining or just masking symptoms.

For situations where repeated endoscopy isn’t practical, fecal calprotectin has become a workhorse biomarker. It’s a protein released by white blood cells that accumulate in inflamed intestinal tissue, and it can be measured from a simple stool sample. Periodic monitoring of fecal calprotectin is now considered a cornerstone for tracking treatment response and detecting flare-ups before symptoms return.¹³

Another biomarker gaining traction is intestinal fatty acid-binding protein (I-FABP), a molecule normally found inside the cells lining the gut. When those cells are damaged and die, I-FABP spills into the blood and urine. In newborns at risk for necrotizing enterocolitis, a severe form of intestinal damage, combining I-FABP with fecal calprotectin has shown strong diagnostic accuracy, with one study reporting a sensitivity above 90% and specificity above 90% when both markers were used together.¹⁴ The lactulose-mannitol test offers yet another approach, measuring how much of two sugar molecules passes through the gut wall into urine; a higher ratio signals increased permeability.¹⁵

Treatment Approaches That Work

Treatment for intestinal damage depends entirely on the cause, but a few themes run across most scenarios. Removing the offending trigger is always step one: stopping the NSAID, treating the infection, controlling the autoimmune flare, or managing the radiation exposure. Beyond that, strategies focus on calming inflammation, supporting the barrier’s natural repair mechanisms, and preventing complications.

For IBD, biologic therapies targeting TNF, interleukins, or immune cell trafficking have transformed outcomes over the past two decades. The goal has shifted from just controlling symptoms to achieving mucosal healing, meaning the lining looks normal or near-normal on endoscopy. This matters because ongoing invisible inflammation, even without symptoms, predicts complications like strictures, fistulas, and cancer risk down the line.

Nutritional support plays a role in nearly every form of intestinal damage. Short-chain fatty acids, particularly butyrate, serve as the primary fuel source for the cells lining the colon. These molecules are produced when gut bacteria ferment dietary fiber, and they have demonstrated anti-inflammatory effects and a protective role in maintaining the health of the colonic lining.¹⁶ In practical terms, this means a fiber-rich diet feeds the bacteria that produce butyrate, which in turn feeds and protects the gut lining. When someone is too sick to eat, or when the damage is too severe for oral nutrition, enteral or parenteral feeding can keep the body nourished while the gut recovers.

Probiotics and the Barrier

The idea that probiotics can help repair a damaged gut has moved beyond speculation. A meta-analysis pooling data from 26 randomized trials found that probiotics significantly improved multiple measures of gut barrier function, including markers of tight junction integrity and reductions in circulating endotoxin levels.¹⁷ Not all strains are equal, though. Specific strains of Lactobacillus, Bifidobacterium, E. coli Nissle 1917, Bacillus subtilis, and the yeast Saccharomyces boulardii have shown the most consistent ability to strengthen barrier integrity, working through mechanisms like boosting tight junction protein levels and dampening inflammatory signaling.¹⁸

The caveat: most of the strongest evidence comes from cell culture and animal models, and the clinical data, while promising, is still catching up. Taking a random probiotic off the shelf isn’t guaranteed to help, and in severely immunocompromised people, live bacteria supplements can occasionally cause harm. Strain specificity matters more than marketing claims on the label.

When Surgery Becomes Necessary

Severe intestinal damage sometimes requires surgical intervention. Ischemia that has killed a segment of bowel, a perforation from deep ulceration, or uncontrollable bleeding may all necessitate removing the damaged section. In trauma settings or emergencies, surgeons sometimes perform damage control operations where the injured bowel is left in discontinuity (the cut ends aren’t immediately reconnected) to be addressed in a follow-up surgery once the patient stabilizes. This approach, while life-saving, carries its own risks: studies have found higher rates of bowel ischemia at the second operation when the bowel was left disconnected compared to when it was reconnected right away.¹⁹

For Crohn’s disease patients who don’t respond to medications, surgery to remove a narrowed or severely inflamed segment is common, though the disease frequently recurs at or near the surgical site. In ulcerative colitis, removing the entire colon (colectomy) is curative, but it’s a last resort that fundamentally changes how the body handles waste.

The Systemic Ripple Effect

One of the more compelling areas of recent research is the connection between a leaky gut and diseases that seem to have nothing to do with digestion. When the intestinal barrier fails, bacterial components, especially LPS, translocate into the bloodstream.²⁰ This low-grade endotoxemia triggers a chronic inflammatory state that has been linked to insulin resistance, fatty liver disease, and vascular dysfunction.²¹

In a large population study, blood markers of gut permeability, particularly zonulin and LPS-binding protein, were significantly associated with higher triglycerides and elevated C-reactive protein, a general marker of inflammation.²² This doesn’t prove that a leaky gut causes metabolic syndrome, since the relationship could run in both directions, but it does suggest that intestinal barrier health is intertwined with cardiovascular and metabolic risk in ways that weren’t appreciated even a decade ago.

Organoids and the Future of Gut Repair

For damage that the body can’t repair on its own, researchers are developing a radically different approach: growing miniature intestines in a lab and transplanting them into the damaged bowel. These structures, called intestinal organoids, are generated from human stem cells and contain multiple cell types that mirror the real intestine’s architecture. In a recent study, fragmented human intestinal organoids delivered into injured rodent bowel engrafted, proliferated, and persisted, restoring not just the inner mucosal lining but also incorporating into the muscle layer and blood vessel lining of the intestinal wall.¹⁴ In the engrafted regions, human cells made up roughly half of the cells within the repaired tissue, and the new lining showed functional characteristics consistent with a working intestine.²³

Organoid transplantation has potential advantages over simple stem cell infusions because the organoids already have a tissue-like structure and retain the genetic characteristics of the intestinal region they’re derived from, making them more likely to integrate into the host tissue and function normally once transplanted.²⁴ This technology is still in early-stage animal research, but it represents the closest thing science has to a genuine regenerative solution for intestinal damage that current therapies can’t fix, including short bowel syndrome after extensive surgical resections and refractory Crohn’s disease.

Experimental Barrier-Boosting Compounds

Beyond probiotics and organoids, several novel compounds are being studied for their ability to strengthen the intestinal barrier directly. One recent example is seleno-chitooligosaccharide, a selenium-containing derivative of chitin (a natural compound found in crustacean shells). In a mouse model, this compound significantly increased the expression of the tight junction proteins ZO-1 and occludin in the small intestine, suggesting it could help prevent the seal between cells from breaking down in the first place.²⁵ Other experimental agents being explored include urolithin A (a metabolite derived from pomegranate and walnuts that appears to reduce C. difficile toxin activity) and various plant-derived polyphenols that target the inflammatory pathways responsible for loosening tight junctions.

None of these are ready for clinical use, and the gap between showing an effect in a mouse and proving it helps a human patient is famously wide. But the volume of research in this space reflects a growing recognition that supporting barrier integrity, rather than just suppressing inflammation after the barrier has already failed, could be the next frontier in treating intestinal damage.